Family · Pharmaceutical analytical standards
Sofosbuvir
An antiviral that blocks the hepatitis C virus polymerase, approved in 2013. Combined with other antivirals it cures the infection in over 90% of patients in about three months. This family brings together the active ingredient, metabolites, labelled standards and other impurities.
Did you know?It turned hepatitis C, once treated with months of interferon and many side effects, into a disease cured with tablets.
No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
